
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇻🇳VN · Medicine#154500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
250 to 1.5K🎙 Weekly cadence·19 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇻🇳100% - Active Followers
Loyal subscribers who consistently listen
150 to 900
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 1 epsHosts
Not detected.
Recent guests
Recent episodes
Psychedelic Assisted Psychotherapy and Integration Pt 2 with Dr. Aryan Sarparast and Will Lucas
Jul 1, 2026
Unknown duration
Psychedelic Assisted Psychotherapy and Integration Pt 1 w/ Dr. Aryan Sarparast and Will Lucas
Jan 23, 2026
1h 31m 26s
Delirium with Dr. Kamalika Roy and Dr. Jonathan Floriani
Jun 27, 2025
Unknown duration
Autism Spectrum with Dr. Randall Phelps and Dr. Amelia Roth
Apr 3, 2025
Unknown duration
Bipolar Disorder with Dr. Julie Anderson & Dr. Sean Stanley
Oct 19, 2024
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/1/26 | Psychedelic Assisted Psychotherapy and Integration Pt 2 with Dr. Aryan Sarparast and Will Lucas | Join us in the second half of our discussion with Dr. Aryan Sarparast and clinical researcher Will Lucas. This episode primarily discusses the practice of psychedelic integration.Articles, Books and other Resources: Hu X, Gorman I, Nielson E. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Curr Top Behav Neurosci. 2026;77:397-416. doi: 10.1007/7854_2024_529. PMID: 39654004.Examples of Psychedelic Integration Trainings: CIIS, IPI, FLUENCE, TCAL, PCAL Moezzi, Melody. The Rumi Prescription: How an Ancient Mystic Poet Changed My Modern Manic Life. TarcherPerigee, 2020. [1]Grof, Stanislav. The Way of the Psychonaut: Stanislav Grof's Journey of Consciousness. Multidisciplinary Association for Psychedelic Studies (MAPS), 2019. [1, 2]The Shulgin Foundation: https://shulginfoundation.orgWomen's Visionary Council: https://visionarycongress.org | — | ||||||
| 1/23/26 | Psychedelic Assisted Psychotherapy and Integration Pt 1 w/ Dr. Aryan Sarparast and Will Lucas✨ | Psychedelic Assisted Psychotherapyharm reduction+3 | Dr. Aryan SarparastWill Lucas | OHSU Psilocybin Education & Assessment Collaborative for ExcellenceOregon Psilocybin Services+2 | — | psychedelic therapypsilocybin+4 | — | 1h 31m 26s | |
| 6/27/25 | Delirium with Dr. Kamalika Roy and Dr. Jonathan Floriani | Join us for a fascinating conversation about delirium work up and management in a primarily inpatient setting with OHSU consult liaison psychiatrists Dr. Kamalika Roy and Dr. Jonathan Floriani. | — | ||||||
| 4/3/25 | Autism Spectrum with Dr. Randall Phelps and Dr. Amelia Roth | Dive into an informative conversation with Developmental and Behavioral Pediatricians Dr. Randall Phelps & Dr. Amelia Roth as we discuss multimodal evaluation for Autism Spectrum Disorder in children, as well as existing supports for patients with ASD and their families and further psychiatric considerations for neurodiverse youth. As a note, we acknowledge that ASD does not solely affect children as more and more individuals are being diagnosed at older ages, partly due to systemic injustice in the medical system. The scope of this episode is limited to workup in a pediatric population. Hosted by Maya Singh Sharkey (she/her) and Harland Harrison (they/them)Questions? Reach out to us at: psychiatryexplored@gmail.com | — | ||||||
| 10/19/24 | Bipolar Disorder with Dr. Julie Anderson & Dr. Sean Stanley | Join us as psychiatrists Dr. Julie Anderson and Dr. Sean Stanley unravel the complexities of Bipolar Disorder. In the second and final part of our series on mood disorders, they discuss the diagnosis of Bipolar disorder, including the distinctions between Bipolar I and II, as well as pharmacologic and psychosocial therapies for patients with bipolar disorder. This discussion of Bipolar disorder is ideal for medical learners, physicians, and anyone curious about the subject. We will be discussing manic, hypomanic, and major depressive episodes in our discussion of Bipolar Disorders. Full diagnostic criteria for those episodes can be found in Section 2 of the DSM-V under Bipolar and related disorders. References: 1. The Sydney Bipolar Screener 2. VVA/DOD Clinical Practice Guidelines for Management of Bipolar Disorder 3. National Collaborating Centre for Mental Health (UK). Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care. London: The British Psychological Society and The Royal College of Psychiatrists; 2014 Sep. PMID: 29718639. (2014, some updates 2023) 4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. | — | ||||||
| 12/14/23 | Major Depressive Disorder with Dr. Julie Anderson & Dr. Sean Stanley | Tag along as psychiatrists Dr. Julie Anderson and Dr. Sean Stanley unravel the complexities of Major Depressive Disorder (MDD). In this first of two podcasts on mood disorders, they explain MDD's neurological basis, diagnosis, suicide risk assessment, and treatments ranging from medications to psychotherapy to lifestyle changes. A thoughtful discussion of MDD's multifaceted impacts ideal for medical learners, physicians, and interested minds alike. References: Patient Health Questionnaire (PHQ-9 & PHQ-2) Collaborative Care Model Columbia-Suicide Severity Rating Scale (C-SSRS) My Resilience in Adolescence (MYRIAD) Project Barbui, C., Cipriani, A., & Geddes, J. R. (2008). Antidepressants and suicide symptoms: compelling new insights from the FDA’s analysis of individual patient level data. BMJ Ment Health, 11(2), 34-35. Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. Jama, 303(1), 47-53. | — | ||||||
| 10/25/23 | Transcranial Magnetic Stimulation (TMS) with Dr. Brandon Cornejo and Dr. Justin Laporte | Join Psychiatrists, Dr. Brandon Cornejo & Dr. Justin Laporte, for a stimulating talk about all things Transcranial Magnetic Stimulation (TMS). Hosts: Candace Chan, MS4 & Devon Boorstein-Holler, MS4 Have Questions? Feel free to reach out to us at: psychiatryexplored@gmail.com References: rTMS for Craving in Methamphetamine Use Disorder, a clinical trial Carmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., ... & Zohar, J. (2019). Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. American Journal of Psychiatry, 176(11), 931-938. Roth, Y., Tendler, A., Arikan, M. K., Vidrine, R., Kent, D., Muir, O., ... & Zangen, A. (2021). Real-world efficacy of deep TMS for obsessive-compulsive disorder: post-marketing data collected from twenty-two clinical sites. Journal of psychiatric research, 137, 667-672. Voigt, J. D., Leuchter, A. F., & Carpenter, L. L. (2021). Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. Translational psychiatry, _11_(1), 330. | — | ||||||
| 10/5/23 | Functional Neurological Disorder (FND) with Dr. Jordan Anderson & Dr. Joel Mack | Join Neuropsychiatrist Dr. Jordan Anderson and Psychiatrist Dr. Joel Mack in an expansive discussion on the fascinating world of Functional Neurological Disorders. Questions? psychiatryexplored@gmail.com References: https://neurosymptoms.org (Signs and symptoms of FND's including functional tremor & examples of entrainment) Baslet, G., Seshadri, A., Bermeo-Ovalle, A., Willment, K., & Myers, L. (2016). Psychogenic non-epileptic seizures: an updated primer. _Psychosomatics_, _57_(1), 1-17 LaFrance WC Jr, Miller IW, Ryan CE, Blum AS, Solomon DA, Kelley JE, Keitner GI. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009 Apr;14(4):591-6. doi: 10.1016/j.yebeh.2009.02.016. Epub 2009 Feb 20. PMID: 19233313. Perez DL, Edwards MJ, Nielsen G, Kozlowska K, Hallett M, LaFrance WC Jr. Decade of progress in motor functional neurological disorder: continuing the momentum. J Neurol Neurosurg Psychiatry. 2021 Mar 15:jnnp-2020-323953. doi: 10.1136/jnnp-2020-323953 The Dancing Plague of 1518 | — | ||||||
| 8/9/23 | Emergency Psychiatry with Dr. David Do & Dr. James Koved | Dive into an enlightening conversation with Dr. David Do & Dr. James Koved as they shed light on the specialized realm of psychiatric emergency rooms, the challenges faced in modern mental health care, and the evolving landscape of emergency psychiatry. Hosted by Candace Chan & Devon Boorstein-Holler Questions? Reach out to us at: psychiatryexplored@gmail.com | — | ||||||
| 4/18/23 | Electroconvulsive Therapy (ECT) w/ Dr. Fang, Dr. Hocker, and Dr. Guzman-Seda | Join Psychiatrists Dr. Anne Fang, Dr. Veronica Rita Hocker, and Anaesthesiologist Dr. Natalia Guzman-Seda as they explore the electrifying clinical landscape of Electroconvulsive Therapy. Hosted by Candace Chan & Kathleen Daily-Jensen Questions? psychiatryexplored@gmail.com | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/25/23 | [Bonus] Sleep Medicine Q&A with Candace Chan & Devon Boorstein-Holler | Third-year OHSU medical students, Candace Chan and Devon Boorstein-Holler rehash the information from our first sleep medicine & psychiatry talk in a question-and-answer format. This episode is part of a project to help determine optimal podcast formats for student learning. Hosted by: Devon Boorstein-Holler, MS3 & Candace Chan, MS3 Questions? psychiatryexplored@gmail.com Studies Mentioned: Overview on the pharmacology of sleep: https://aasm.org/resources/pdf/pharmacologictreatmentofinsomnia.pdf Study on melatonin in OTC: https://jcsm.aasm.org/doi/full/10.5664/jcsm.6434 NEJM Bob Sack review melatonin for jet lag: https://www.nejm.org/doi/10.1056/NEJMcp0909838?url_ver=Z39.88-%202003&rft_id=ori:rid:crossref.org&rfr_dat-cr_pub%20%200pubmed Study on two groups with insomnia or not, odds to develop depression: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108260/ Resource for online CBTI: https://www.sleepfoundation.org/insomnia/treatment/cognitive-behavioral-therapy-insomnia CBTI for depression: https://academic.oup.com/sleep/article/31/4/489/2454177?login=true IRT vs. IRT+CBT vs. Prazosin: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265653/ | — | ||||||
Showing 11 of 11
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.